Effect of COVID-19 on management of type 1 diabetes:Pushing the boundaries of telemedical healthcare

作     者：Ines Bilic Curcic Maja Cigrovski Berkovic Tomislav Kizivat Silvija Canecki Varzic Robert Smolic Martina Smolic 

作者机构：Department of EndocrinologyUniversity Hospital OsijekOsijek 31000Croatia Department of PharmacologyFaculty of Medicine OsijekOsijek 31000Croatia Department of EndocrinologyDiabetesMetabolism and Clinical PharmacologyUniversity Hospital DubravaZagreb 10000Croatia Department of Kinesiological Anthropology and MethodologyFaculty of KinesiologyUniversity of ZagrebZagreb 10000Croatia Clinical Institute of Nuclear Medicine and Radiation ProtectionUniversity Hospital OsijekOsijek 31000Croatia Department of Nuclear Medicine and OncologyFaculty of Medicine OsijekOsijek 31000Croatia Department of Internal MedicineFamily Medicineand HistoryFaculty of Medicine OsijekOsijek 31000Croatia Department of PathophysiologyFaculty of Medicine OsijekOsijek 31000Croatia Department of PathophysiologyPhysiology and ImmunologyFaculty of Dental Medicine and HealthOsijek 31000Croatia Department of Pharmacology and BiochemistryFaculty of Dental Medicine and HealthOsijek 31000Croatia 

出 版 物：《World Journal of Diabetes》 (世界糖尿病杂志（英文版）（电子版）)

年 卷 期：2021年第12卷第6期

页      面：780-785页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：Supported by Ines Bilić-Ćurčić No.ZUP2018-90 

主　　题：Diabetes management Telemedicine COVID-19 Diabetes type 1 

摘      要：The new coronavirus disease 2019(COVID-19)pandemic posed a great burden on health care systems worldwide and is an enormous and real obstacle in providing needed health care to patients with chronic diseases such as *** to COVID-19,there have been great advances in technology used for management of type 1 diabetes,primarily insulin pumps,sensors,integrated and closed loop systems,ambulatory glucose profile software,and smart phone apps providing necessary essentials for telemedicine implementation right at the beginning of the COVID-19 *** results of these remote interventions are reassuring in terms of glycemic management and hemoglobin A1c ***,data on long-term outcomes and cost reductions are missing as well as proper technical infrastructure and government health policy support.